project id: TCGA-STAD; case submitter id: TCGA-BR-A4J5; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.23; rna integrity number: 7.0; age at index: 56; days to birth: -20714; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1956; age at diagnosis: 20714; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 862.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 83; days to sample procurement: 0; initial weight: 1580.0; portion submitter id: TCGA-BR-A4J5-01A-21; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 40.0; percent tumor nuclei: 70.0;